Wolfe Research Upgrades Celldex Therapeutics (CLDX) to Outperform
Tweet Send to a Friend
(Updated - March 23, 2026 5:43 AM EDT)
Wolfe Research analyst Andy Chen upgraded Celldex Therapeutics (NASDAQ: CLDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wolfe Research analyst Andy Chen upgraded Celldex Therapeutics (NASDAQ: CLDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
